Which Endpoints Matter Most in Transthyretin Amyloid Cardiomyopathy Trials? Are We Comparing Apples to Apples?
Listen now
Description
Do you know how to interpret the results of recent phase 3 clinical trials in patients with transthyretin amyloid cardiomyopathy (ATTR-CM)?
Credit available for this activity expires: 3/22/25
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1000444?ecd=bdc_podcast_libsyn_mscpedu
More Episodes
How can we provide culturally safe care for patients with schizophrenia who are members of underserved communities?
Credit available for this activity expires: 4/26/25
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1000734?ecd=bdc_podcast_libsyn_mscpedu
Published 04/29/24
Published 04/29/24
Are you screening all adults for viral hepatitis, as recommended by the Centers for Disease Control and Prevention (CDC)? Join 2 experts in a discussion of best practices.
Credit available for this activity expires: 04/25/25
Earn Credit / Learning Objectives & Disclosures: ...
Published 04/29/24
Links
Genres
Artwork or description wrong?
Request an update »
Updates may take a few minutes.
Do you host a podcast?
Track your ranks and reviews from Spotify, Apple Podcasts and more.
See hourly chart positions and more than 30 days of history.
Get Chartable Analytics »
See hourly chart positions and more than 30 days of history.
